| Number(%) |
| Sex |
Women |
7 (17.5) |
| |
Men |
33 (82.5) |
| Mean/median age |
59.2/62 (DS 11.83) |
| Localization |
| |
Pharynx |
7(17.5) |
| |
Larynx |
18(45) |
| |
Oral Cavity |
9(22.5) |
| |
Unknown primary |
4(10) |
| |
Others |
2(5) |
| Histology |
Epidermoid |
36(90) |
| |
undifferentiated |
2(5) |
| |
Adenocarcinoma |
1(2.5) |
| |
Others |
1(2.5) |
| T |
Tx |
5(12.5) |
| |
T1-2 |
10(30.3) |
| |
T3-4 |
18(54.54) |
| N |
N0-1 |
19(54.28) |
| |
N2 |
13(37.14) |
| |
N3 |
3(8.57) |
| Initial Stage |
I |
4(11.76) |
| |
II |
2(5.88) |
| |
III |
10(29.41) |
| |
IV |
18(52.94) |
| Radiotherapy |
Mean dose |
65.94Gy |
| Toxicity |
Acute (>G3) |
9(22.5) |
| |
Chronicle (>G2) |
2(5) |
| Treatment |
RT alone |
5(12.5) |
| Scheme |
| |
Surgery and RT |
13(32.5) |
| |
RTQT |
13(32.5) |
| |
Surgery and RTQT |
9(22.5) |
| Disease Free Interval |
Mean 33.5 /Median 16 |
| Interval between treatments |
Mean 44.77/Median 23.5 |
|
